| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_ZEB1_0009300 | Intron-Intron | chr10:31644455-31644601 | chr10:31355526-31355672 | 147 nt | 0.4490 |
| hsa_ZEB1_0009400 | Intron-Intron | chr10:31644897-31645062 | chr10:31355968-31356133 | 166 nt | 0.3313 |
| hsa_ZEB1_0009500 | Intron-Intron | chr10:31645091-31645350 | chr10:31356162-31356421 | 260 nt | 0.2423 |
| hsa_chr10_0275700 | Intergenic-Intergenic | chr10:31645912-31646992 | chr10:31356983-31358063 | 1081 nt | 0.3562 |
| hsa_ZEB1_0009700 | Intron-Intron | chr10:31647074-31655054 | chr10:31358145-31366125 | 342 nt | 0.4561 |
| hsa_ZEB1_0009800 | Intron-Exon-Intron | chr10:31647074-31676195 | chr10:31358145-31387266 | 143 nt | 0.4476 |
| hsa_ZEB1_0009900 | Intron-Exon-Intron | chr10:31647074-31676727 | chr10:31358145-31387798 | 411 nt | 0.4380 |
| hsa_ZEB1_0009600 | Intron-Exon-Intron | chr10:31647074-31784767 | chr10:31358145-31495838 | 250 nt | 0.3960 |
| hsa_chr10_0275800 | Intergenic-Intergenic | chr10:31647193-31648352 | chr10:31358264-31359423 | 1160 nt | 0.3233 |
| hsa_ZEB1_0010000 | Intron-Intron | chr10:31650694-31651144 | chr10:31361765-31362215 | 451 nt | 0.6829 |
A study in humans identified the circZEB1 as a potential biomarker for immune-mediated demyelinating disease, where its levels in cerebrospinal fluid exosomes were specifically validated [Misir et al. DOI:10.1038/s41418-022-00948-7]. A study in humans demonstrated that circZEB1 was upregulated in left atrial appendages of patients with atrial fibrillation [Tian et al. DOI:10.3390/molecules26041155].